logo
  Join        Login             Stock Quote

ISIS Pharmaceuticals (ISIS) Tumbles After CHMP Adopts Negative Opinion On Kynamro

 December 14, 2012 08:13 AM
 


(By Balachander) ISIS Pharmaceuticals Inc. (NASDAQ: ISIS) shares tumbled in Friday premarket trading after an European Committee recommended the refusal of the marketing authorisation for its lead product Kynamro intended to treat high blood cholesterol levels, citing saftety concerns.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on Thursday adopted a negative opinion for Kynamro for the treatment of patients with an inherited disease causing high blood cholesterol levels, called familial hypercholesterolaemia.

The CHMP was of the opinion that the benefits of Kynamro did not outweigh its risks and recommended that it be refused marketing authorisation.

[Related -Futures Down Ahead Of Service Sector Data; Compugen Ltd. (CGEN) Soars]

The Committee noted that a high proportion of patients stopped taking the medicine within two years, mainly due to side effects such as flu-like symptoms, injections site reactions and liver toxicity. The Committee was also concerned that a greater proportion of patients taking Kynamro experienced serious cardiovascular events (problems with the heart and blood vessels) than patients taking placebo.

"This prevented the CHMP from concluding that Kynamro's intended cardiovascular benefit, in terms of reducing cholesterol levels, outweighed its cardiovascular risk," CHMP said.

Genzyme, a Sanofi company (NYSE: SNY) and ISIS' partner, plans to request a re-examination of the CHMP Opinion.

[Related -Futures Down On China Worries; Vanguard Health Systems Inc. (VHSSurge]

In October 2012, KYNAMRO received a positive vote by an U.S. Food and Drug Administration (FDA) advisory panel that Genzyme had provided sufficient efficacy and safety data to support the marketing of KYNAMRO to treat HoFH.

ISIS shares dropped 8.95 percent in Friday pre-market trade.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageXerox Corp. (XRX): An Insider’s $500,000 Insider Buy

Last week was a healthy week of insider buying as 194 companies reported purchase records. The number read on...

article imageQihoo 360 Technology Co Ltd. (QIHU) Q2 Earnings Preview: A Green Monday

Qihoo 360 Technology Co Ltd. (NYSE:QIHU) will report its second quarter 2014 financial results on Monday, read on...

article imageSix Stocks that Could Outperform in the next 90 days

Earlier today, Goldman Sachs put out its list of the 50 stocks that Matter Most. It’s a list of the 50 read on...

article imageFoot Locker, Inc. (FL) Q2 Earnings Preview: Running Past the Street View

Foot Locker, Inc. (NYSE:FL) plans to report financial results for its second quarter ended August 2, 2014 read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.